Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Eléments de l'association

Latium210
Giuseppe Nappi10
Latium Sauf Giuseppe Nappi" 206
Giuseppe Nappi Sauf Latium" 6
Latium Et Giuseppe Nappi 4
Latium Ou Giuseppe Nappi 216
Corpus10303
\n\n\n\n \n

List of bibliographic references

Number of relevant bibliographic references: 4.
Ident.Authors (with country if any)Title
001A21 Karla Eggert [Allemagne] ; David Squillacote [États-Unis] ; Paolo Barone [Italie] ; Richard Dodel [Allemagne] ; Regina Katzenschlager [Autriche] ; Murat Emre [Turquie] ; Andrew Lees (neurologue) [Royaume-Uni] ; Olivier Rascol [France] ; Werner Poewe [Autriche] ; Eduardo Tolosa [Espagne] ; Claudia Trenkwalder [Allemagne] ; Marco Onofrj [Italie] ; Fabrizio Stocchi [Italie] ; Giuseppe Nappi [Italie] ; Vladimir Kostic [Serbie] ; Jagoda Potic [Serbie] ; Evzen Ruzicka [République tchèque] ; Wolfgang Oertel [Allemagne]Safety and efficacy of perampanel in advanced Parkinson's disease: A randomized, placebo‐controlled study
002368 Roberta Zangaglia [Italie] ; Claudio Pacchetti [Italie] ; Chiara Pasotti [Italie] ; Francesca Mancini [Italie] ; Domenico Servello [Italie] ; Elena Sinforiani [Italie] ; Silvano Cristina [Italie] ; Marco Sassi [Italie] ; Giuseppe Nappi [Italie]Deep brain stimulation and cognitive functions in Parkinson's disease: A three‐year controlled study
003227 Elena Sinforiani [Italie] ; Roberta Zangaglia [Italie] ; Raffaele Manni [Italie] ; Silvano Cristina [Italie] ; Enrico Marchioni [Italie] ; Giuseppe Nappi [Italie] ; Francesca Mancini [Italie] ; Claudio Pacchetti [Italie]REM sleep behavior disorder, hallucinations, and cognitive impairment in Parkinson's disease
004115 Francesca Mancini [Italie] ; Roberta Zangaglia [Italie] ; Silvano Cristina [Italie] ; Maria Grazia Sommaruga [Italie] ; Emilia Martignoni [Italie] ; Giuseppe Nappi [Italie] ; Claudio Pacchetti [Italie]Double‐blind, placebo‐controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in parkinsonism

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024